SpringerLink
Log in

The role of serological testing in idiopathic interstitial pneumonia: a rheumatologist perspective

  • Interstitial Lung Disease (E Alhamad, Section Editor)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

The diagnosis of idiopathic interstitial pneumonias (IIPs) is complex and requires multidisciplinary approach. Identifying an underlying connective tissue disease (CTD) is associated with a better prognosis and should be routinely evaluated. Serological testing is an important tool in detecting patients with CTDs and differentiating them from patients with IIP. This article will highlight the importance of serological testing in patients with IIPs and the role of the rheumatologist in evaluating these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.

    Article  Google Scholar 

  2. Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.

    Article  PubMed  Google Scholar 

  3. Travis WD, Hunninghake G, King Jr TE, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008;177(12):1338–47.

    Article  PubMed  Google Scholar 

  4. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni G, et al. Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Eur Respir J. 2011;38(2):384–91.

    Article  CAS  PubMed  Google Scholar 

  5. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med. 2003;167(10):1410–5.

    Article  PubMed  Google Scholar 

  6. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175(7):705–11.

    Article  PubMed  Google Scholar 

  7. Habash-Bseiso DE, Yale SH, Glurich I, Goldberg JW. Serologic testing in connective tissue diseases. Clin Med Res. 2005;3(3):190–3.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest. 2013;143(3):814–24. A review article covering aspects of connective tissue disease-associated interstitial lung disease.

  9. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

    Article  PubMed  Google Scholar 

  10. Dequeker J, Van Noyen R, Vandepitte J. Age-related rheumatoid factors. Incidence and characteristics. Ann Rheum Dis. 1969;28(4):431–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Guo YP, Wang CG, Liu X, Huang YQ, Guo DL, **g XZ, et al. The prevalence of antinuclear antibodies in the general population of China: a cross-sectional study. Curr Ther Res Clin Exp. 2014;76:116–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Lane SK, Gravel Jr JW. Clinical utility of common serum rheumatologic tests. Am Fam Physician. 2002;65(6):1073–80.

    PubMed  Google Scholar 

  13. Alhamad EH, Cal JG, AlBoukai AA, Shaik SA, Omair MA. Autoimmune symptoms in idiopathic pulmonary fibrosis: clinical significance. Clin Respir J. 2014;13. A study demonstrating an improved survival in IPF patients with the presence of symptoms of connective tissue diseases rather than autoantibodies.

  14. Cakmakci Karadogan D, Balkarli A, Onal O, Altinisik G, Cobankara V. The role of nailfold capillaroscopy in interstitial lung diseases—can it differentiate idiopathic cases from collagen tissue disease associated interstitial lung diseases? Tuberk Toraks. 2015;63(1):22–30. A study demonstrating the role of nailfold capillaroscopy in detecting occult connective tissue diseases.

  15. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest. 2010;138(2):251–6.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H, et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest. 2009;136(4):1072–8.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991;18(9):1282–4.

    CAS  PubMed  Google Scholar 

  18. Aho K, von Essen R, Kurki P, Palosuo T, Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol. 1993;20(8):1278–81.

    CAS  PubMed  Google Scholar 

  19. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–6.

    Article  PubMed  Google Scholar 

  20. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741–9.

    Article  PubMed  Google Scholar 

  21. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford). 2009;48(6):607–12.

    Article  CAS  Google Scholar 

  22. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23(8):881–8.

    Article  CAS  PubMed  Google Scholar 

  23. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007;19(6):523–9.

    Article  PubMed  Google Scholar 

  24. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis. 2001;60(2):116–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984;160(2):420–34.

    Article  CAS  PubMed  Google Scholar 

  26. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 1986;163(5):1281–91.

    Article  CAS  PubMed  Google Scholar 

  27. Targoff IN, Trieu EP, Plotz PH, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 1992;35(7):821–30.

    Article  CAS  PubMed  Google Scholar 

  28. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993;91(6):2556–64.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162(4):2315–20.

    CAS  PubMed  Google Scholar 

  30. Hashish L TE, Sadanandan P, Targoff, IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome. Arthritis Rheum. [Abstract]. 2005;52(S312).

  31. Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 2007;46(6):1005–8.

    Article  CAS  Google Scholar 

  32. Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med. 1990;88(3):241–51.

    Article  CAS  PubMed  Google Scholar 

  33. Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007;56(4):1295–303.

    Article  CAS  PubMed  Google Scholar 

  34. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford). 2007;46(5):842–5.

    Article  CAS  Google Scholar 

  35. Fischer A, Swigris JJ, du Bois RM, Lynch DA, Downey GP, Cosgrove GP, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med. 2009;103(11):1719–24.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44(10):1282–6.

    Article  CAS  Google Scholar 

  37. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J. 2006;28(5):1005–12.

    Article  CAS  PubMed  Google Scholar 

  38. Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26(10):1647–54.

    Article  PubMed  Google Scholar 

  39. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol. 2012;24(6):602–8.

    Article  CAS  PubMed  Google Scholar 

  40. Catoggio LJ, Bernstein RM, Black CM, Hughes GR, Maddison PJ. Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis. 1983;42(1):23–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Weiner ES, Earnshaw WC, Senecal JL, Bordwell B, Johnson P, Rothfield NF. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum. 1988;31(3):378–85.

    Article  CAS  PubMed  Google Scholar 

  42. Douvas AS, Achten M, Tan EM. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979;254(20):10514–22.

    CAS  PubMed  Google Scholar 

  43. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980;23(6):617–25.

    Article  CAS  PubMed  Google Scholar 

  44. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther. 2003;5(2):80–93.

    Article  CAS  PubMed  Google Scholar 

  45. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest. 1993;91(4):1399–404.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Hirakata M, Okano Y, Pati U, Suwa A, Medsger Jr TA, Hardin JA, et al. Identification of autoantibodies to RNA polymerase II occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III. J Clin Invest. 1993;91(6):2665–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Hardin JA, Rahn DR, Shen C, Lerner MR, Wolin SL, Rosa MD, et al. Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. J Clin Invest. 1982;70(1):141–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, et al. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984;4(1):40–4.

    Article  CAS  PubMed  Google Scholar 

  49. Hanke K, Bruckner CS, Dahnrich C, Huscher D, Komorowski L, Meyer W, et al. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther. 2009;11(1):R22.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger Jr TA. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 2003;48(1):203–9.

    Article  PubMed  Google Scholar 

  51. Fischer A, Meehan RT, Feghali-Bostwick CA, West SG, Brown KK. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest. 2006;130(4):976–81.

    Article  PubMed  Google Scholar 

  52. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.

    Article  PubMed  Google Scholar 

  53. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.

    Article  CAS  PubMed  Google Scholar 

  54. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23(5):581–90.

    Article  Google Scholar 

  56. Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol. 2015;42(1):60–3.

    Article  PubMed  Google Scholar 

  57. Fautrel B, Combe B, Rincheval N, Dougados M. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis. 2012;71(3):386–9.

    Article  PubMed  Google Scholar 

  58. Rodnan GP, Fennell Jr RH. Progressive systemic sclerosis sine scleroderma. JAMA. 1962;180:665–70.

    Article  CAS  PubMed  Google Scholar 

  59. Horswell RR, Hargrove Jr MD, Peete WP, Ruffin JM. Scleroderma presenting as the malabsorption syndrome. A case report. Gastroenterology. 1961;40:580–2.

    CAS  PubMed  Google Scholar 

  60. Poormoghim H, Lucas M, Fertig N, Medsger Jr TA. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum. 2000;43(2):444–51.

    Article  CAS  PubMed  Google Scholar 

  61. Homma Y, Ohtsuka Y, Tanimura K, Kusaka H, Munakata M, Kawakami Y, et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration. 1995;62(5):248–51.

    Article  CAS  PubMed  Google Scholar 

  62. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007;176(7):691–7.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Pereira DA, Dias OM, de Almeida GE, Araujo MS, Kawano-Dourado LB, Baldi BG, et al. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features. J Bras Pneumol. 2015;41(2):151–60. A study describing a cohort of patients with lung dominant connective tissue disease and their outcome.

  64. Omote N, Taniguchi H, Kondoh Y, Watanabe N, Sakamoto K, Kimura T, et al. Lung-dominant connective tissue disease: clinical, radiologic and histologic features. Chest. 2015;7. A study describing a cohort of patients with lung dominant connective tissue disease.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This article contains no studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine (38), King Khalid University Hospital, College of Medicine, King Saud University, PO Box 2925, Riyadh, 11461, Saudi Arabia

    Mohammed A. Omair

Authors
  1. Mohammed A. Omair
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed A. Omair.

Additional information

This article is part of the Topical Collection on Interstitial Lung Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omair, M.A. The role of serological testing in idiopathic interstitial pneumonia: a rheumatologist perspective. Curr Pulmonol Rep 4, 130–134 (2015). https://doi.org/10.1007/s13665-015-0118-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-015-0118-4

Keywords

Search

Navigation